iMedia Brands Inc IMBI:NASDAQ

Last Price$5.26NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.31(5.57%)
Bid (Size)$5.22 (12)
Ask (Size)$5.28 (3)
Day Low / High$5.22 - 5.67
Volume117.3 K
  • Latest Stories
  • Commentary and Analysis
--DA Davidson Adjusts iMedia Brands PT to $23 From $15, Maintains Buy Rating
10:53AM ET 11/18/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

iMedia Brands Net Loss Widens in Fiscal Q3 While Sales Jump; Raises Fiscal 2022 Revenue Guidance
6:39AM ET 11/17/2021 MT Newswires

iMedia Brands (IMBI) reported a fiscal Q3 net loss of $0.44 per share, wider than a loss of $0.39 per share a year ago. Four analysts polled by Capital IQ...

-- Earnings Flash (IMBI) IMEDIA BRANDS Posts Q3 Revenue $130.7M, vs. Street Est of $127.3M
6:03AM ET 11/17/2021 MT Newswires

...

iMedia Brands Prices Offering of $75 Million Senior Notes
3:50AM ET 9/24/2021 MT Newswires

iMedia Brands (IMBI) priced a public offering of $75 million of 8.50% senior notes due 2026, according to a Thursday press release. Underwriters have a...

iMedia Brands to Buy 123tv
7:33AM ET 9/22/2021 MT Newswires

iMedia Brands (IMBI) on Wednesday agreed to buy interactive media company 123tv in a deal with an enterprise value of about $95 million and an earn-out...

Lake Street Adjusts iMedia Brands PT to $15 From $19, Maintains Buy Rating
11:01AM ET 8/25/2021 MT Newswires

iMedia Brands (IMBI) has an average rating of Buy and price targets ranging from $15 to $22, according to analysts polled by Capital IQ. (MT Newswires...

--DA Davidson Adjusts iMedia Brands PT to $15 From $19, Maintains Buy Rating
10:35AM ET 8/25/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Top Midday Decliners
1:39PM ET 8/24/2021 MT Newswires

Theravance Biopharma (TBPH) said late Monday its experimental ulcerative colitis treatment izencitinibx did not meet the primary endpoint in a phase 2b...

iMedia Brands Swings to Q2 Loss as Sales Decline
7:04AM ET 8/24/2021 MT Newswires

iMedia Brands (IMBI) on Tuesday swung to a Q2 loss of $0.22 per share from earnings of $0.11 per share a year earlier. Four analysts polled by Capital IQ...

-- Earnings Flash (IMBI) IMEDIA BRANDS Posts Q2 Revenue $113.4M, vs. Street Est of $120.8M
6:00AM ET 8/24/2021 MT Newswires

...